How Can We Help You?
Locations | Global Affiliations  
Open

Blog

 HomeBizzell US  Blog
Categories Insights Tags Alcohol Use Disorder (AUD), Behavioral Health, BHARC, Mental Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH)

Dr. David Sleet, Senior Associate at Bizzell Co-authors Article on Alcohol Harms in Young Adults in The Lancet

A new analysis from the Institute of Health Metrics and Evaluation at the University of Washington, Seattle, suggests that for young adults aged 15-39, there are no health benefits to drinking alcohol, only harms. The harms they are most likely to experience are injuries.

The study, published in The Lancet July 16, 2022, (doi: 10.1016/S0140-6736(22)00847-9), used data from the Global Burden of Diseases, a project based at the University of Washington in Seattle that tracks health trends worldwide and produces comprehensive data on the causes of illness and death in the world.

Both males and females under age 40 risked health loss from alcohol use, even when consuming small amounts of alcohol. But for those older than 40, consuming small amounts of alcohol (such as 1-2 glasses of wine daily) can provide some health benefits, yet health risks vary by age and region.

David Sleet, Ph.D., one of the co-authors of the article and a Senior Associate for Injury Prevention at Bizzell US (Bizzell), noted that “We need stronger interventions tailored towards younger individuals to reduce the substantial global health loss, particularly from injuries, attributable to alcohol use.”

The study’s authors call for alcohol consumption guidelines to be revised to emphasize that health risks of alcohol use differ by age, stressing that the level of alcohol consumption recommended by many existing guidelines is too high for young people. They also call for policies targeting males under age 40, who are most likely to use alcohol harmfully.

The study was funded by the Bill & Melinda Gates Foundation.

“I would like to congratulate Dr. Sleet and the other contributing authors on the publication of the report in The Lancet. As alcohol sales have soared during the pandemic, the long-term health risks of heavy drinking including brain and liver damage, heart disease, digestive disease, and mental health disorders have increased. I urge all Americans to fight the deadly epidemic of alcohol use and abuse, particularly among adolescents and young adults” said Anton C. Bizzell, M.D., President & CEO of Bizzell.

To date, the publication has received national media attention, with USA Today, and The Guardian covering the report.

To read the reviews, please see below:
https://www.usatoday.com/story/news/health/2022/07/15/alcohol-health-risks-under-40/10067144002/
https://www.theguardian.com/society/2022/jul/14/alcohol-is-never-good-for-people-under-40-global-study-finds

About BHARC
The Behavioral Health Advancement Resource Center (BHARC) is an authoritative source for behavioral health information, insights, technical assistance, training, and innovative tools. BHARC is a mechanism to share evidence-based behavioral health interventions and best practices. The BHARC Advisory Council consists of experts in substance use, mental health, clinical trials, pharmaceuticals, and healthcare standards and quality. Learn more about the Behavioral Health Advancement Resource Center at BHARC.org.

About Bizzell
Established in 2010, Bizzell US is U.S. Small Business Administration (SBA) HUBZone-certified strategy, consulting, and technology firm with a mission to improve lives and accelerate change. Bizzell US develops innovative solutions to some of the most critical issues of our time such as health care services equity, global health, workforce innovation and other urgent needs facing the world. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown into a thriving firm headquartered in New Carrollton, Maryland with staff and offices in various regions around the country including California, Colorado, Oklahoma, and Georgia, and globally in Africa, Asia, and Central America. Learn more about how we develop data-driven, research-informed, innovative solutions to complex-real-world challenges. Learn more at BizzellUS.com.

ARTICLE REFERENCE:
GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.

Lancet   2022 Jul 16;400(10347):185-235. doi: 10.1016/S0140-6736(22)00847-9. PMID: 35843246 PMCID: PMC9289789

happy people stacking hands outdoor
Categories Mental Health, News, Substance Abuse and Mental Health Services Administration (SAMHSA), Substance Use Disorder Tags Behavioral Health, News, Substance Abuse and Mental Health Services Administration (SAMHSA), Substance Use Disorder (SUD)

Bizzell Awarded Four SAMHSA IDIQ Domains

Bizzell US (Bizzell), a global strategy, consulting, and technology firm, is excited to continue its successful partnership with the Substance Abuse and Mental Health Services Administration (SAMHSA). Bizzell has been awarded four domains as a prime contractor on SAMHSA’s Indefinite Delivery Indefinite Quantity (IDIQ) contract through 2027. The IDIQs help SAMHSA achieve its goal of reducing the impact of substance abuse and mental illness on America’s communities.

Through this award, Bizzell is eligible to compete for new contracts under the following domains:

  • Domain I: Feasibility, Pilot, and Evaluation Projects
  • Domain II: Statistical Projects
  • Domain V: Technical Assistance and Training Projects
  • Domain VI: Planning, Implementation, and Report Support Projects (8a and HUBZone)

Since Bizzell’s inception, the firm has worked with SAMHSA and other agencies within the Department of Health and Human Services to accelerate behavioral health advancements and improve services and resources for communities within the United States and across the globe. Bizzell has a full range of capabilities that can support SAMHSA’s mission, and includes program and project management, data analytics, evaluation and learning, and technical assistance and training.

Bizzell has conducted a wide range of feasibility studies, evaluation projects, and didactic learning seminars to strengthen health system interventions and training, foster data-informed decisions, and improve program outcomes and impact. Specifically, we’ve partnered with SAMHSA to provide direct technical assistance and support services to opioid treatment programs nationwide. Additionally, we’ve delivered in-person and web-based provider trainings in the areas of prevention treatment and recovery, substance use disorder and maternal and infant health, effective uses of medication assisted treatment, and improving cultural competence in substance abuse treatment.

“As a company, Bizzell is passionate about developing innovative solutions that lead to positive health outcomes,” says Anton Bizzell, M.D., President and CEO of Bizzell. “We are energized to support SAMSHA’s critical work to advance the nation’s behavioral health—especially now as more people struggle with mental health and substance use concerns and the demand for effective and accessible behavioral health services is growing.”

About Bizzell

Established in 2010, Bizzell US is U.S. Small Business Administration (SBA) HUBZone certified strategy, consulting, and technology firm with a mission to improve lives and accelerate change. Bizzell US develops innovative solutions to some of the most critical issues of our time such as health care services equity, global health, workforce innovation and other urgent needs facing the world. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown into a thriving firm headquartered in New Carrollton, Maryland with staff and offices in various regions around the country including California, Colorado, Oklahoma, and Georgia, and globally in Africa, Asia, and Central America. Learn more about how we develop data-driven, research-informed, innovative solutions to complex-real-world challenges. Learn more at BizzellUS.com.

The Bizzell Group Contact
Chad Brown DM, Chief Administrative Officer
301-459-0100 | cbrown@thebizzellgroup.com

Categories BHARC Tags Behavioral Health, BHARC, Health, National Institute on Drug Abuse (NIDA), Substance Use Disorder (SUD)

Utilizing Behavioral Therapy to Address Stimulant Use Disorder

Utilizing Behavioral Therapy to Address Stimulant Use Disorder

Bizzell US, in partnership with The University of Vermont’s Center on Rural Addiction has produced an interactive educational video for clinicians and practitioners highlighting Contingency Management options for addressing stimulant use disorders.

With rural stimulant overdoses now higher than in urban counties (6.7 vs 4.8 per 100,000.)[1], a renewed focus on combating addiction within these remote communities has taken on a new sense of urgency. “This video adds an important, well studied tool for addressing stimulant use disorder,” said Dr. Todd Mandell of Bizzell US who specializes in substance use and mental health and who was the lead producer of the educational video.

According to the Centers for Disease Control and Prevention (CDC), in 2018, 40% of all overdose deaths were attributed to stimulate use. Until recently there have not been medical treatment alternatives for practitioners treating patients with stimulant use disorder which makes the use of Contingency Management even more urgent.

The video highlights the history of the development of Contingency Management and stresses the key components of a successful program.

To view the educational video please visit: http://uvmcm.modernepic.net

[1] Hedegaard H, Spencer MR. Urban–rural differences in drug overdose death rates, 1999–2019. NCHS Data Brief, no 403. Hyattsville, MD: National Center for Health Statistics. 2021. DOI: https://dx.doi.org/10.15620/cdc:102891

group of people in a circle looking down at the camera
Categories News Tags CEO News, Health, Healthcare, National Cancer Institute (NCI), Tobacco Research

Bizzell Supports Development of Comprehensive Report Addressing Smoking Cessation Treatment within Cancer Care Settings

Bizzell Supports Development of Comprehensive Report Addressing Smoking Cessation Treatment within Cancer Care Settings

 

July 27, 2022 (New Carrollton, MD) — The Bizzell Group is proud to provide direct support to the National Cancer Institute, part of the National Institutes of Health, in the development of Tobacco Control Monograph 23—Treating Smoking in Cancer Patients: An Essential Component of Cancer Care. Released on June 29th, the monograph expands upon prior research from the 2014 and 2020 Surgeon General’s reports to inform clinicians and their patients with cancer about the science and practice of quitting smoking. The monograph also builds on recent findings from the National Cancer Institute’s (NCI) Moonshot℠ Cancer Center Cessation Initiative (C3I) program. “The monograph provides evidence that clinicians, public health practitioners, researchers, and patients with cancer can use to help influence real-world change in the treatment of patients with cancer who smoke. I am grateful for the opportunity to collaborate with NCI and subject matter experts to produce a rigorous volume on such an important topic,” said Jenny Twesten, Managing Director of Health Communications & Research at Bizzell, who oversaw the editorial and publication support for the monograph.

Smoking cessation treatment is rarely addressed in cancer care settings, yet the research summarized in the monograph demonstrates that quitting smoking is among the most effective treatment options for improving the likelihood of survival, quality of life, and overall health of people with cancer who smoke. The monograph also provides clinicians with evidence-based strategies and treatment options they can implement to better address smoking with cancer patients.
“Monograph 23 leverages prior academic research to demonstrate that addressing smoking cessation within the cancer treatment protocol yields tremendous benefits. I am greatly appreciative of the rigorous development process led by the Federal staff, Scientific Editorial Committee, peer-review experts, and the Bizzell team” said Anton C. Bizzell, M.D., President and CEO of Bizzell.

To read the full monograph, please visit: https://cancercontrol.cancer.gov/brp/tcrb/monographs/monograph-23

About Bizzell

Established in 2010, Bizzell US is U.S. Small Business Administration (SBA) HUBZone certified strategy, consulting, and technology firm with a mission to improve lives and accelerate change. Bizzell US develops innovative solutions to some of the most critical issues of our time such as health care services equity, global health, workforce innovation and other urgent needs facing the world. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown into a thriving firm headquartered in New Carrollton, Maryland with staff and offices in various regions around the country including California, Colorado, Oklahoma, and Georgia, and globally in Africa, Asia, and Central America. Learn more about how we develop data-driven, research-informed, innovative solutions to complex-real-world challenges. Learn more at BizzellUS.com.

1 2 3 4 5 … 39
Copyright © 2023 Bizzell US All rights reserved.
Bizzell US